In June 2019, four days after my 25th birthday, I was under the knife having my left testicle removed, a procedure called orchiectomy.
For the preceding two-and-a-half years, I had experienced an increasingly painful ache with even minor contact "downstairs." I also noticed the left testicle slowly getting bigger. I quietly attended appointments with "Dr. Google" that always ended immediately after the search results suggested "testicular cancer."
I didn't want to know the worst-case scenario, so I tried my best to avoid thinking it into reality.
The time I allowed to pass gave my cancer the opportunity to metastasize to a lymph node in my retroperitoneum—the anatomical space behind the abdominal cavity—which caused the discomfort that ultimately led me to my primary care doctor. For that reason, from July 15 to Oct. 4, I was treated with high-dose chemotherapy: four cycles of etoposide and cisplatin, more commonly known as EPx4.
My post-chemo CT scan revealed my lymph node had shrunk, but not enough to be considered "no evidence of disease" (NED). As a result, I traveled to Indiana University, where doctors performed a post-chemo retroperitoneal lymph node dissection (PC-RPLND). Removing my retroperitoneal lymph nodes, in conjunction with the subsequent pathology results, earned me NED status.
I've been considered a survivor since November 2019 and have taken the ball into my own court to raise as much awareness as I can. I am now on the board of the Testicular Cancer Awareness Foundation and I host a podcast called "It Takes Balls," where I talk with survivors and medical providers.
Even given my experience with the disease and my subsequent advocacy, I wish I had known a handful of details about testicular cancer before it happened to me.